At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
EQ Equillium Inc.
Post-Mkt 02-25 16:59:17 EST
1.83
-0.09
-4.69%
盘后1.82
-0.01-0.55%
16:41 EST
High1.94Low1.82Vol287.67K
Open1.94D1 Closing1.92Amplitude6.51%
Mkt Cap111.43MTradable Cap79.65MTotal Shares60.89M
T/O534.20KT/O Rate0.66%Tradable Shares43.52M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Samsung Unveils Galaxy Buds4 Series: Ultimate Hi-Fi Sound with Enhanced Comfort and Fit
prnewswire  ·  02:00
Samsung Unveils Galaxy Buds4 Series: Ultimate Hi-Fi Sound with Enhanced Comfort and Fit
EQ Resources Limited (EQR) Gets a Buy from Canaccord Genuity
TIPRANKS  ·  02-25 22:16
EQ Resources Limited (EQR) Gets a Buy from Canaccord Genuity
EQ Resources Completes Documents for Prepayment Facility Repayable via Set-Off Against Monthly Tungsten Oxide Concentrate Deliveries, Shares Fall 3%
MT Newswires Live  ·  02-24 10:10
EQ Resources Completes Documents for Prepayment Facility Repayable via Set-Off Against Monthly Tungsten Oxide Concentrate Deliveries, Shares Fall 3%
EQ Resources Refinances Spanish Debt With €15m Traxys Prepayment Deal
TIPRANKS  ·  02-24 08:08
EQ Resources Refinances Spanish Debt With €15m Traxys Prepayment Deal
Equillium COO Christine Zedelmayer Disposes of Common Shares
Reuters  ·  02-24 01:53
Equillium COO Christine Zedelmayer Disposes of Common Shares
Is EQ Resources’ (ASX:EQR) Boardroom Challenge Reframing Its Capital Strategy And Investor Voice?
Simply Wall St.  ·  02-16
Is EQ Resources’ (ASX:EQR) Boardroom Challenge Reframing Its Capital Strategy And Investor Voice?
EQ Resources (ASX:EQR) Valuation In Focus As Boardroom Challenge Draws Investor Attention
Simply Wall St.  ·  02-14
EQ Resources (ASX:EQR) Valuation In Focus As Boardroom Challenge Draws Investor Attention
EQ Resources Applies to Quote Additional Ordinary Shares on ASX
TIPRANKS  ·  02-11
EQ Resources Applies to Quote Additional Ordinary Shares on ASX
EQ Resources Admits ASX Placement Rule Breaches, Tightens Governance Controls
TIPRANKS  ·  02-10
EQ Resources Admits ASX Placement Rule Breaches, Tightens Governance Controls
EQ Resources Issues New Shares via Option Exercise and Confirms Regulatory Compliance
TIPRANKS  ·  02-10
EQ Resources Issues New Shares via Option Exercise and Confirms Regulatory Compliance
EQ Resources Director Increases Equity Stake Through Option Exercise
TIPRANKS  ·  02-09
EQ Resources Director Increases Equity Stake Through Option Exercise
EQ Resources Seeks ASX Quotation for 4.6 Million New Shares
TIPRANKS  ·  02-09
EQ Resources Seeks ASX Quotation for 4.6 Million New Shares
EQ Resources Seeks ASX Quotation for 7.6 Million New Shares
TIPRANKS  ·  02-05
EQ Resources Seeks ASX Quotation for 7.6 Million New Shares
EQ Resources Director Increases Shareholding Through Option Conversion
TIPRANKS  ·  02-03
EQ Resources Director Increases Shareholding Through Option Conversion
BRIEF-Equillium Reports Inducement Grants Under Nasdaq Listing Rule
Reuters  ·  02-03
BRIEF-Equillium Reports Inducement Grants Under Nasdaq Listing Rule
Equillium gewährt neuen Mitarbeitern Aktienoptionen im Rahmen des 2024 Inducement Plans
Reuters  ·  02-03
Equillium gewährt neuen Mitarbeitern Aktienoptionen im Rahmen des 2024 Inducement Plans
EQ Resources Issues New Shares on Option Exercise and Lodges Cleansing Notice
TIPRANKS  ·  02-02
EQ Resources Issues New Shares on Option Exercise and Lodges Cleansing Notice
A Look At EQ Resources (ASX:EQR) Valuation After A Tungsten Focused Share Price Surge
Simply Wall St.  ·  01-31
A Look At EQ Resources (ASX:EQR) Valuation After A Tungsten Focused Share Price Surge
EQ Resources Issues Over 6.1 Million New Shares on Option Exercise
TIPRANKS  ·  01-30
EQ Resources Issues Over 6.1 Million New Shares on Option Exercise
Why EQ Resources (ASX:EQR) Is Up 34.5% After New Share Issue And Tungsten Sector Buzz - And What's Next
Simply Wall St.  ·  01-29
Why EQ Resources (ASX:EQR) Is Up 34.5% After New Share Issue And Tungsten Sector Buzz - And What's Next

Introduction

Company Name.
Equillium Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. Equillium, Inc. was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. The company was incorporated in 2017 and is headquartered in La Jolla, California.
Issue price:
--